Max Beugeling

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2019
Publications (10 Years): 2

Top Topics

Molecularly Imprinted

Ulcerative Colitis

Top Venues

Rijksuniversiteit Groningen

Rijksuniversiteit Groningen (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rijksuniversiteit Groningen

Netherlands

PhD student :: Pharmaceutical Technology and Biopharmacy

Education History

Rijksuniversiteit Groningen

Netherlands

MSC

Rijksuniversiteit Groningen

Netherlands

BSC

Publications

Bahez Gareb, Silke Posthumus, Max Beugeling, Pauline Koopmans, Daan J Touw, Gerard Dijkstra, Jos G W Kosterink, Henderik W Frijlink
Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process. Pharmaceutics 11 (9) (2019)
Katie Amssoms, Philip A Born, Max Beugeling, Ben De Clerck, Ellen Van Gulck, Wouter L J Hinrichs, Henderik W Frijlink, Niels Grasmeijer, Guenter Kraus, Roger Sutmuller, Kenny Simmen, Lieven Baert
Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice. PloS one 13 (8) (2018)